Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finafloxacin vs ciprofloxacin for lower uncomplicated urinary tract infection
2007-007742-35Phase 2Terminated
- Sponsor
- MerLion Pharmaceuticals
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of finafloxacin in urinary tract infection (UTI) (2 arms), sponsored by MerLion Pharmaceuticals. Primary endpoint: Bacteriological eradication of initial pathogen at Day 4–6. Started Mar 2008; status: terminated.
02
Drugs
finafloxacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2007-007742-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007742-35.